LAS VEGAS, Nev. – By Min Kyeong-joong/Korea Biomedical Review correspondent -- The world’s largest consumer electronics show CES 2023 kicked off with CES Unveiled, a preview of key products open exclusively for over 4,700 media outlets, late Tuesday in Las Vegas, the U.S.Unlike in 2022 when some exh
GE HealthCare said that it has completed the previously announced spinoff from General Electrics (GE) and begun trading as an independent company on the Nasdaq exchange under the ticker symbol "GEHC" from Wednesday.The spinoff of GE Healthcare follows GE's decision to split the company into three se
Curexo, a Korean company specializing in medical robots, said that it supplied 21 medical robots in the fourth quarter of 2022, bringing its total to 62 medical robots worldwide in 2022. The 62 medical robots include 39 CUVIS-joints surgical robots, 18 Morning Walks, and 5 InMotion Arms.The company’
“Research and development in medical and biopharmaceutical fields have been made through scientists’ trials and error in the past. Today, however, the insight of artificial intelligence takes the lead in their development through big data in every stage.”Kim Kyeong-nam, a Korea Institute for Science
Humasis, a Korean in-vitro diagnostic medical device company, said Thursday that Celltrion has terminated a contract to supply Humasis' at-home Covid-19 antigen diagnosis kit.The two companies initially signed the contract worth $114.78 million (133.6 billion won) on Jan. 22.However, Humasis explain
LG Electronics said on Monday that it signed a memorandum of understanding (MOU) for research cooperation with a sleep-tech diagnosis company, Asleep, at the LG Electronics Gasan R&D Campus on Friday.Asleep is a sleep tech start-up that diagnoses sleep stages through breathing sounds during sleep an
Boditech Med, a company specializing in in-vitro diagnostic solutions, said on Friday that it signed an exclusive contract with Menarini Diagnostics, an Italian firm, to supply four types of point-of-care diagnostic (POCT) equipment including AFIAS-10, AFIAS IGRA-TB, AFIAS PTH, AFIAS CARBA-5 in Euro
Digital healthcare, which was in the spotlight as the future of medical care and industry, is facing criticism that there is no output compared to input.However, those in the industrial field appeal that they are too tied up with various regulations, including data utilization, to produce results ev
Lunit, a Korean medical artificial intelligence (AI) solutions company, said on Thursday it signed a contract to supply AI breast cancer screening solutions to large hospitals in Hong Kong and Mongolia.Lunit will supply mammography AI image analysis solution, Lunit Insight MG, to Hong Kong's largest
VUNO said on Wednesday that a multi-institutional study demonstrated the cardiac arrest predictive performance of VUNO Med-DeepCARS to monitor the risk of severe deterioration of pediatric inpatients when doctors and nurses were not around.Previous studies show that the number of cardiopulmonary res
Medtronic Korea said Monday it appointed Yoo Seung-rok, the senior marketing director at the company, as its new vice president and managing director.Yoo joined Medtronic Korea as Chief Financial Officer (CFO) in 2010 and was in charge of overall support and operations for the company, including fin
Neurophet, a Korean medical AI company, said on Monday that it signed an exclusive agreement with Clairvo Technologies to sell Neurophet Aqua, its flagship degenerative neurological disease diagnosis assistant software, in Japan.Earlier in March, Neurophet obtained medical device certification for N
The Ministry of Health and Welfare (MOHW) and the Ministry of Food and Drug Safety (MFDS) said on Thursday that they collaborated with three other government institutions to select three digital health technology solutions as the first "innovative medical devices" under a new evaluation system.Two a
Coreline Soft, a medical artificial intelligence (AI) company, said on Friday that it obtained medical device certification (pre-market authorization) from the Singapore Health Sciences Authority (HSA) for nine of its AI-based solutions on Saturday.The certificate includes AVIEW products for analysi
GC Corp. said Thursday that its patch-type influenza vaccine MIMIX-Flu, a co-development item with U.S. Vaxess Technologies, proved safety and immunogenicity in a phase 1 trial.MIMIX-Flu is a device that combines GC's influenza vaccine antigen with Vaxess's patch-based subcutaneous drug delivery tec
Lunit said on Thursday that a study published in the January 2023 issue of The Lancet Regional Health–Americas, demonstrated the effectiveness of Lunit’s INSIGHT CXR as a triage tool for tuberculosis (TB) screening in prisons.Globally, prisons are high-risk settings for TB. In South America, TB case
Bionote said Monday that it confirmed the final public offering price at 9,000 won ($6.90) due to demand forecast from institutional investors from last Thursday to Friday.While the company initially planned to offer 13 million depository receipts at the offering price range of 18,000 won to 22,000
Noul said it signed the memorandum of understanding (MoU) with Ghana Infectious Disease Center (GIDC) to cooperate on strengthening onsite malaria diagnostic capability in Ghana.According to the company, Ghana’s population of about 30 million is exposed to the risk of malaria.“There are more than fi
SD Biosensor said it delayed the acquisition date of Meridian Bioscience, a U.S. diagnostics company.According to a public filing on Monday, SD Biosensor said it will revise the expected date of acquiring stocks and investment securities of Meridian Bioscience from Jan. 7 to Jan. 31, 2023."This is a
Conflict over Humasis’s management control is deepening between CEO Cha Jeong-hak and the company’s minority shareholders.However, the company’s share prices have sharply risen ahead of the extraordinary shareholders meeting scheduled for February to discuss the participation in management by the un